Enhancing the potency of in vivo lentiviral vector mediated gene therapy to hepatocytes
Abstract In vivo gene therapy to the liver using lentiviral vectors (LV) may represent a one-and-done therapeutic approach for monogenic diseases. Increasing LV gene therapy potency is crucial for reducing the effective doses, thus alleviating dose-dependent toxicities and facilitating manufacturing...
Saved in:
| Main Authors: | Cesare Canepari, Michela Milani, Chiara Simoni, Francesco Starinieri, Monica Volpin, Anna Fabiano, Mauro Biffi, Fabio Russo, Rossana Norata, Martina Rocchi, Chiara Brombin, Federica Cugnata, Eugenio Montini, Francesca Sanvito, Markus Grompe, Alessio Cantore |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-05-01
|
| Series: | Nature Communications |
| Online Access: | https://doi.org/10.1038/s41467-025-60073-0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Genome editing for scalable production of alloantigen‐free lentiviral vectors for in vivo gene therapy
by: Michela Milani, et al.
Published: (2017-08-01) -
Lentiviral-based approach for the validation of cancer therapeutic targets in vivo
by: Chiara Ambrogio, et al.
Published: (2014-10-01) -
Hepatocyte senescence and persistent liver injury in Fanconi anemia
by: Jane Koo, et al.
Published: (2025-03-01) -
Pervasive supply of therapeutic lysosomal enzymes in the CNS of normal and Krabbe‐affected non‐human primates by intracerebral lentiviral gene therapy
by: Vasco Meneghini, et al.
Published: (2016-03-01) -
Hospitalité et hostilité : le multilinguisme à l’épreuve du « bien-écrire »
by: Chiara Montini
Published: (2014-04-01)